MeSH term
Frequency | Condition_Probility | Adolescent | 4 | 0.0 |
Adult | 14 | 0.0 |
Child | 4 | 0.0 |
Female | 21 | 0.0 |
Gene Frequency | 10 | 0.0 |
Genotype | 17 | 0.0 |
Humans | 36 | 0.0 |
Interleukin-1/*genetics | 18 | 22.0 |
Male | 20 | 0.0 |
Polymorphism, Genetic/genetics | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 26 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
Polymorphism, Genetic | 8 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Aged | 9 | 0.0 |
Base Sequence | 8 | 0.0 |
DNA Primers | 3 | 0.0 |
Middle Aged | 12 | 0.0 |
*Polymorphism, Single Nucleotide | 3 | 0.0 |
Risk Factors | 5 | 0.0 |
*Polymorphism, Genetic | 10 | 0.0 |
Sialoglycoproteins/*genetics | 2 | 3.0 |
Genetic Markers | 3 | 0.0 |
Linkage Disequilibrium | 4 | 0.0 |
Alleles | 11 | 0.0 |
Case-Control Studies | 4 | 0.0 |
Haplotypes | 2 | 0.0 |
Interleukin-1/genetics | 3 | 4.0 |
Odds Ratio | 4 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Tumor Necrosis Factor-alpha/genetics | 3 | 1.0 |
Chi-Square Distribution | 2 | 0.0 |
Confidence Intervals | 3 | 0.0 |
Cytokines/*genetics | 2 | 1.0 |
Homozygote | 2 | 0.0 |
Microsatellite Repeats/genetics | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Introns | 2 | 0.0 |
Lod Score | 2 | 0.0 |
*Antiretroviral Therapy, Highly Active | 2 | 0.0 |
CD4 Lymphocyte Count | 2 | 0.0 |
HIV Infections/*drug therapy/genetics | 2 | 28.0 |
HIV-1/*genetics | 2 | 0.0 |
RNA, Viral/blood | 2 | 0.0 |
T-Lymphocyte Subsets | 2 | 1.0 |
Viral Load | 2 | 0.0 |
Viremia/*genetics | 2 | 100.0 |
Animals | 5 | 0.0 |
Comparative Study | 5 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
*Chromosomes, Human, Pair 2 | 3 | 1.0 |
RNA, Messenger | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Polymorphism, Single Nucleotide | 3 | 0.0 |
Chromosomes, Human, Pair 2 | 2 | 1.0 |
DNA, Satellite/genetics | 2 | 1.0 |
Genes, Structural | 2 | 0.0 |
Pedigree | 2 | 0.0 |
Genetic Predisposition to Disease | 4 | 0.0 |
Membrane Proteins/genetics | 3 | 0.0 |
*Genes, Structural | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Amyloid beta-Protein Precursor/genetics | 2 | 4.0 |
tau Proteins/genetics | 2 | 28.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
